AMPE
Price:
$0.28
Market Cap:
$317.90K
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation; AP-019, an Inhaled Ampion treatment, which is in Phase II clinical trial for the treatment of Adults with Respiratory Distress Due to COVID-19; and AP-018 that is in Phase I clinical trial to treat patients with prolonged...[Read more]
Industry
Biotechnology
IPO Date
2010-03-31
Stock Exchange
OTC
Ticker
AMPE
According to Ampio Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.03. This represents a change of -92.74% compared to the average of -0.41 of the last 4 quarters.
The mean historical PE Ratio of Ampio Pharmaceuticals, Inc. over the last ten years is -3.25. The current -0.03 PE Ratio has changed -7.74% with respect to the historical average. Over the past ten years (40 quarters), AMPE's PE Ratio was at its highest in in the June 2019 quarter at 28.71. The PE Ratio was at its lowest in in the June 2021 quarter at -23.03.
Average
-3.25
Median
-0.59
Minimum
-17.29
Maximum
0.84
Discovering the peaks and valleys of Ampio Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 185.74%
Maximum Annual PE Ratio = 0.84
Minimum Annual Increase = -818.86%
Minimum Annual PE Ratio = -17.29
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | -0.19 | 22.50% |
| 2022 | -0.16 | -97.64% |
| 2021 | -6.65 | -61.52% |
| 2020 | -17.29 | 185.74% |
| 2019 | -6.05 | -818.86% |
| 2018 | 0.84 | -157.70% |
| 2017 | -1.46 | 102.47% |
| 2016 | -0.72 | 55.27% |
| 2015 | -0.46 | 25.80% |
| 2014 | -0.37 | -60.26% |
The current PE Ratio of Ampio Pharmaceuticals, Inc. (AMPE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.33
5-year avg
-6.07
10-year avg
-3.25
Ampio Pharmaceuticals, Inc.’s PE Ratio is less than Better Therapeutics, Inc. (-0.00), less than Calithera Biosciences, Inc. (-0.00), less than Oncology Pharma Inc. (-0.00), less than Innovation1 Biotech Inc. (-0.00), less than Panacos Pharmaceuticals, Inc. (-0.00), less than Tengion, Inc. (-0.00), less than Statera Biopharma, Inc. (-0.00), less than Baudax Bio, Inc. (-0.00), less than Arno Therapeutics, Inc. (-0.00), less than Kaleido Biosciences, Inc. (-0.00),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.00 | $10.90K | |
| -0.00 | $1.46K | |
| -0.00 | $328.66K | |
| -0.00 | $4.49K | |
| -0.00 | $5.37K | |
| -0.00 | $4.03K | |
| -0.00 | $28.57K | |
| -0.00 | $436.00 | |
| -0.00 | $9.87K | |
| -0.00 | $4.26K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ampio Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ampio Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Ampio Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Ampio Pharmaceuticals, Inc. (AMPE)?
What is the highest PE Ratio for Ampio Pharmaceuticals, Inc. (AMPE)?
What is the 3-year average PE Ratio for Ampio Pharmaceuticals, Inc. (AMPE)?
What is the 5-year average PE Ratio for Ampio Pharmaceuticals, Inc. (AMPE)?
How does the current PE Ratio for Ampio Pharmaceuticals, Inc. (AMPE) compare to its historical average?